| Lightcalls.com |
|
|
![]() |
Obesity is a heterogeneous disorder...Obesity is a heterogeneous disorder, the come of genetic and environmental factors, according to Artemis P Simopoulos, MD president of the Center for Genetics, Nutrition and Health, Washington, DC in the September-October 1995 issue of Nutrition Today. She maintains that studies using twins indicate that obesity is familial with able to endure genetic components, although specific gene genetic markers or genetically-determined mechanisms have not even now been identified. In studies of twins according to Stunkard, et al., genetic influences accounted for 70 percent of the differences in material part mass index (BMI) later in life, while childhood environment had little, or no, influence. [ILLUSTRATION OMITTED] Home environment affects weight This does not mean, she adds, that what goe forward in the home environment makes no difference. However, the reflection measured the genetic influence in a range of particular environmental conditions. "One of the greatest in quantity revealing experiences about the general intents of the genes on human corpse fat variation occurs when humans are expos to either a standardized chronic overfeeding treatment or a negative balance regimen," Simopoulos says. As an example, she adds, in the overfeeding consideration with twins by Bouchard, et al., the variation within pairs was the same third of the variation between pairs. In united result, those who gained weight had a rise in diastolic (resting) progeny pressure from 66 to 70 mmHg Central abdominal obesity is related to many other health problems She adds that there is conclusive evidence that obesity located in the central abdominal part of the corpse is statistically associated with a number of metabolic derangements, as it was as insulin resistance, high cholesterol horizontals high blood pressure, non-insulin-dependent diabetes mellitus, etc "Obesity -- particularly central obesity -- high house pressure, diabetes Type II and coronary artery disease cluster in a certain number of families," Simopoulos continues. "These clusters could be mediated within insulin action as has been hypothesized by the agency of Ferrannini. The key dietary constituent (contributing to obesity) could be a decrease in the intake of longer-chain polyunsaturated fatty acids (PUFAs), or too to a great degree trans fatty acid intake (found in a margarines), or an increase in dietary linoleic acid, as was hypothesized by the agency of Simopoulos (in a chart in the Nutrition Today article). She notes that a number of anthropologic, nutritional and genetic studies indicate that humans' overall diet, including vigor intake and energy expenditure, has changed throughout the past 10,000 years, with significant change occurring during the past 150 years in the shadow and amount of fat. "Eaton and Konner have estimated higher intakes for protein, calcium, potassium and vitamin C and lower sodium intakes for the diet of the late paleolithic period than the rife U.S. and Western diet," Simopoulos adds. Three (3) overall dietary changes contribute to obesity Today, she says, industrialized societies are characterized by: 1) an increase in mechanical value intake (calories) combined with a decrease in efficacy expenditure; 2) an increase in the consumption of saturated fat, omega-6 fatty acids (vegetable oils) and trans fatty acids, and a decrease in omega-3 fatty acid intake (salmon, sardines, flax se oil, etc); and 3) a decrease in the consumption of tangled carbohydrates and fiber. "It has been estimated that the existing Western diet is dificient in omega-3 fatty acids, with a ratio of omega-6 to omega-3 of 10 to 14:1 instead of 1:1 as is the case with wild animals and presumably humans," Simopoulos says. She went upon to say that humans evolv forward a diet where there was a balance between the omega-6 and omega-3 fatty acids, which is a more physiological state in names of the production of prostaglandins, leukotrienes, and interleukin-1 (IL-1), immune factors that, when over-produc can lead to inflammation and on a level cell damage. "The current recommendation to substitute vegetable oils (omega-6) for unsaturated fats: leads to unnatural increases in IL-1, prostaglandins and leukotrienes; is not consistent with human evolution; and may lead to maladaptation in those genetically predisposed," Simopoulos adds. She says that, genetically speaking, today we live in a nutritional environment that differs from that for which our genetic constitution was preferableed Therefore, increased dietary intake in the demeanor of sedentary lifestyles leads to overweight and obesity, which is the principally prominent and serious health point in dispute of industrialized societies. Obesity is also the cause of other serious health question s such as heart disease. The rife approach to the treatment of coronary heart disease with positive dietary changes and physics aiming to lower plasma cholesterol concentrations has l to decreases in mortality rate from coronary heart disease, however not to all-cause mortality in undivided study, she continues. "The general recommendation to lower saturated fat and cholesterol ignore other important aspects of diet known to influence lipid horizontals fibrinogen (a protein in the children involved with clotting) levels, and relations vessel wall interactions that are affected by means of a balance of omega-6 and omega-3 essential fatty acids," Simopoulos says. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |